FDA 483 - Steriscience SP. Z O.O. - April 28, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Steriscience Sp. z o.o. in Warsaw, Poland, revealed significant deficiencies in their manufacturing processes for sterile drug products. Observations included inadequate training and qualification of visual inspectors, scientifically unsound laboratory controls for microbial enumeration, and insufficient procedures to prevent microbiological contamination. These issues raise concerns about the quality and sterility assurance of their drug products.
ID · f77e31bb-20ee-49aa-8782-a71ae8148e2f